Reata Pharmaceuticals Inc
RETADelisted Sep 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001358762
Reata Pharmaceuticals Inc was delisted on Sep 26, 2023; its insiders filed their last Form 4 on Sep 28, 2023; 214 institutions reported holding it in 13F filings for Q2 2023, worth $3.21B in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Reata Pharmaceuticals Inc changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 195 | 1 | 183 | −11 |
| Shares | 26.5M | 99.2K | 26.7M | +245.1K (+0.9%) |
| Value | $3.76B | $14.0M | $2.69B | −$1.06B (−28.2%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Reata Pharmaceuticals Inc at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 98,616 | $9.92M | 0.01% |
| Jump Financial, LLC | 22,500 | $2.26M | 0.16% |
| Adage Capital Partners GP, L.L.C. | 17,000 | $1.71M | 0.00% |
| Serengeti Asset Management LP | 15,000 | $1.51M | 1.34% |
| Lazard Asset Management LLC | 11,338 | $1.14M | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 8,795 | $885.0K | 0.00% |
| Citadel Advisors LLC | 6,193 | $623.0K | 0.00% |
| Transcend Wealth Collective, LLC | 5,000 | $485.0K | 0.04% |
| Gyon Technologies Capital Management, LP | 4,753 | $478.0K | 0.13% |
| Millennium Management LLC | 4,263 | $429.0K | 0.00% |
| First Trust Advisors LP | 3,946 | $397.0K | 0.00% |
| Vivid Financial Management, Inc. | 3,176 | $320.0K | 0.13% |
| Inscription Capital, LLC | 3,000 | $302.0K | 0.09% |
| Dynamic Technology Lab Private Ltd | 2,310 | $233.0K | 0.03% |
| Los Angeles Capital Management LLC | 2,257 | $227.0K | 0.00% |
| Federation des caisses Desjardins du Quebec | 60 | $6.04K | 0.00% |
| Dark Forest Capital Management LP | 47 | $5.00K | 0.00% |
| JFS Wealth Advisors, LLC | 24 | $2.00K | 0.00% |
| Bell Investment Advisors, Inc | 15 | $2.00K | 0.00% |
| Meridian Wealth Partners, LLC | 2 | $0 | 0.00% |
Sold out (31)
Institutions that held Reata Pharmaceuticals Inc at the end of Q2 2021 and filed for Q3 2021 without it.
Not filed for Q3 2021 yet (1)
Institutions that held Reata Pharmaceuticals Inc at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 99,155 | $14.0M |